Please contact us if you need further information about the company or its products at contact@axalbion.com.
If you are interested in investing in our company, please contact us at investor@axalbion.com.
The company is conducting a chronic cough clinical trial in the UK. For more information about the trial and the clinical sites where it is being performed, please visit NCT04866563.
